Skip to main navigation Skip to search Skip to main content

Corrigendum: Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab (Annals of Oncology (2017) 28:6 (1368-1379) DOI: 10.1093/annonc/mdx108)

  • N. Chaput
  • , P. Lepage
  • , C. Coutzac
  • , E. Soularue
  • , K. Le Roux
  • , C. Monot
  • , L. Boselli
  • , E. Routier
  • , L. Cassard
  • , M. Collins
  • , T. Vaysse
  • , L. Marthey
  • , A. Eggermont
  • , V. Asvatourian
  • , E. Lanoy
  • , C. Mateus
  • , C. Robert
  • , F. Carbonnel

Research output: Contribution to journalComment/debate

84 Citations (Scopus)

Abstract

In the original article, there were errors in Figure 3B and the accompanying legend. These have been corrected online as below.

Original languageEnglish
Pages (from-to)2012
Number of pages1
JournalAnnals of Oncology
Volume30
Issue number12
DOIs
Publication statusPublished - 1 Dec 2019

Fingerprint

Dive into the research topics of 'Corrigendum: Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab (Annals of Oncology (2017) 28:6 (1368-1379) DOI: 10.1093/annonc/mdx108)'. Together they form a unique fingerprint.

Cite this